Biohaven Pharmaceutical Holding Company Ltd BHVN:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 06/18/21 EDT
95.05quote price arrow up+0.06 (+0.06%)
Volume
28,845
Close
94.99quote price arrow up+0.72 (+0.76%)
Volume
2,969,942
52 week range
57.66 - 106.56

...

Loading . . .
  • Open94.50
  • Day High97.19
  • Day Low93.49
  • Prev Close94.27
  • 52 Week High106.56
  • 52 Week High Date06/11/21
  • 52 Week Low57.66
  • 52 Week Low Date08/11/20

Key Stats

  • Market Cap6.181B
  • Shares Out65.07M
  • 10 Day Average Volume0.84M
  • Dividend-
  • Dividend Yield-
  • Beta1.00
  • YTD % Change10.83

KEY STATS

  • Open94.50
  • Day High97.19
  • Day Low93.49
  • Prev Close94.27
  • 52 Week High106.56
  • 52 Week High Date06/11/21
  • 52 Week Low57.66
  • 52 Week Low Date08/11/20
  • Market Cap6.181B
  • Shares Out65.07M
  • 10 Day Average Volume0.84M
  • Dividend-
  • Dividend Yield-
  • Beta1.00
  • YTD % Change10.83

RATIOS/PROFITABILITY

  • EPS (TTM)-14.25
  • P/E (TTM)-6.67
  • Fwd P/E (NTM)-8.50
  • EBITDA (MRQ)-714.892M
  • ROE (MRQ)-805.56%
  • Revenue (MRQ)106.30M
  • Gross Margin (MRQ)71.65%
  • Net Margin (MRQ)-809.99%
  • Debt To Equity (MRQ)-265.20%

EVENTS

  • Earnings Date08/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Biohaven Pharmaceutical Holding Company Ltd

Profile

MORE
Biohaven Pharmaceutical Holding Company Ltd. is a biopharmaceutical company. The Company is engaged in the identification and development of clinical-stage compounds targeting orphan neurologic indications and other neurological pathways. The Company's glutamate platform includes three clinical-stage product candidates being developed for the treatment of various neurological indications: trigriluzole for the treatment of obsessive-compulsive disorder (OCD), spinocerebellar...
Declan Doogan M.D.
Chairman
Vlad Coric M.D.
Chief Executive Officer
James Engelhart CPA
Chief Financial Officer
Address
215 Church St
New Haven, CT
06510-1803
United States

Top Peers

SYMBOLLASTCHG%CHG
ASND
Ascendis Pharma A/S
140.95+2.95+2.14%
PACB
Pacific Biosciences of California Inc
29.15-0.40-1.35%
VIR
Vir Biotechnology Inc
46.15+2.33+5.32%
TWST
Twist Bioscience Corp
111.25-2.20-1.94%
XLRN
Acceleron Pharma Inc
128.24+0.92+0.72%